Comorbidities in psoriatic arthritis: a systematic review and meta-analysis
Rheumatology International · 2021-02 · 41 (2) · 275-284
DOI: 10.1007/s00296-020-04775-2 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Rheumatology International, online erschienen am 09.01.2021. Verfasst von Sonal Gupta und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, University of Liverpool, Liverpool, UK. Hauptthemen laut MEDLINE: Quality of Life. Die Arbeit wurde bisher 173-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The aims of this systematic review and meta-analysis were to: (1) describe the prevalence of commonly reported comorbidities in psoriatic arthritis (PsA), (2) compare the incidence and/or prevalence of comorbidities between PsA and control populations; and (3) examine the impact of comorbidities on PsA outcomes. We systematically searched Medline, PubMed, Scopus, and Web of Science using a predefined protocol in accordance with PRISMA guidelines. Studies reporting only one comorbidity, or a few closely related diseases within one organ system, were excluded. Where possible, meta-analysis was performed using random-effects models. We included 39 studies amounting to over 152 thousand PsA patients. We performed meta-analysis for the prevalence of 21 commonly reported comorbidities. The most prevalent comorbidities were hypertension (pooled prevalence 34%), metabolic syndrome (29%), obesity (27%), hyperlipidaemia (24%) and any cardiovascular diseases (19%). Eleven studies consistently showed higher prevalence of comorbidities in PsA than controls. Five studies showed that comorbid patients had more severe disease, poorer quality of life, and increased discontinuation of treatment. Comorbidities, particularly cardiometabolic disorders, were highly prevalent in PsA and more common than in healthy controls. Comorbidities were associated with adverse disease features, but more research is needed on their impact on longitudinal outcomes such as treatment response, work productivity and mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine, University of Liverpool, Liverpool, UK.
- Department of Medicine, Liverpool University Hospitals, Liverpool, UK.
- Department of Health Data Science, Institute of Population Health, University of Liverpool, Liverpool, UK.
- Musculoskeletal Biology, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, L69 3GA, UK. s.zhao8@liverpool.ac.uk.
Zitieren
APA
Gupta, S., Syrimi, Z., Hughes, D. M., & Zhao, S. S. (2021). Comorbidities in psoriatic arthritis: a systematic review and meta-analysis. Rheumatology International, 41(2), 275-284. https://doi.org/10.1007/s00296-020-04775-2
Vancouver
Gupta S, Syrimi Z, Hughes DM, Zhao SS. Comorbidities in psoriatic arthritis: a systematic review and meta-analysis. Rheumatology International. 2021;41(2):275-284. doi:10.1007/s00296-020-04775-2
BibTeX
@article{Gupta2021,
author = {Gupta, Sonal and Syrimi, Zoe and Hughes, David M and Zhao, Sizheng Steven},
title = {Comorbidities in psoriatic arthritis: a systematic review and meta-analysis},
journal = {Rheumatology International},
year = {2021},
volume = {41},
number = {2},
pages = {275--284},
doi = {10.1007/s00296-020-04775-2}
}
EUVIMED